Antitumor activity of a ROR1 × CD3 bispecific antibody in non-small cell lung cancer.
Wang Y, Zhang Y, Sun H, Chen J, Yang H, Zhong Z, Xiao X, Li Y, Tang Y, Lu H, Tang X, Zhang M, Wu W, Zhou S, Yang J.
Wang Y, et al.
Int Immunopharmacol. 2023 Oct;123:110686. doi: 10.1016/j.intimp.2023.110686. Epub 2023 Jul 25.
Int Immunopharmacol. 2023.
PMID: 37499397